News from the Nucleic Acid Chemistry Center at UMass Chan Medical School

UMass Chan presented “scientist-in-training” lab coats to Lake View Elementary School, one of the 11 North Quadrant schools in Worcester that are part of the UMass Chan North Quadrant Support Services Initiative.

PhD student Valeria Sanabria, MD, won the Zelda Haidak Scholarship in Cell Biology, which was established to enhance training for women pursuing research careers in cell biology. Her research is focused on studying gene expression at the transcriptional level.

UMass Chan Medical School hosted 23 science teachers from six Worcester middle schools to train them on the light microscopes recently donated to their classrooms by the Medical School, thanks to a grant from the Moderna Foundation.

Representatives from UMass Chan presented on several topics and career paths, including RNA Therapeutics Institute, ScienceLive, community and government relations, diversity and inclusion and media and arts in sciences.

UMass Chan Medical School scientists Phillip D. Zamore, PhD, and Roger J. Davis, PhD, FRS, were elected to the National Academy of Medicine on Oct. 9 for their distinguished contributions to medicine and health.

A new RNA therapeutic for preeclampsia is based on work by UMass Chan researchers and collaborating scientists. Researchers explain the importance of a multipronged approach to addressing factors underlying health disparities in this Science for Living article.

The UMass Chan community gathered to celebrate 53 PhD candidates and MD/PhD students who transitioned from student to candidate for a doctoral degree during the 2022-2023 academic year.

PhD candidate John Girgenrath has received a competitive award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to conduct fertility research.

Water Safe Worcester’s summer session is underway every Wednesday night through the end of August. The program is free and open to all teenagers in the Worcester area.

The BRIDGE Fund supports critical research milestones for inventions and discoveries that have high potential to change the course of disease and continues to grow, increasing from approximately $1 million per year in 2019 to $3 million in 2024.